Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Potential prognostic value of isolated tumour cells in breast cancer sentinel nodes

ECCO 15 - ESMO 34

Published: 4 Nov 2009

Views: 14207

Rating:

Save

Dr Marjut Leidenius - Breast Surgery Unit, Helsinki University Central Hospital

Dr Marjut Leidenius from the Breast Surgery Unit, Helsinki University Central Hospital discusses her work with the prognostic value of isolated tumour cells in breast cancer sentinel nodes. Speaking at ECCO 15 - ESMO 34, Berlin, 2009.

Related Videos

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM

Dr Elias Mai - Heidelberg University, Heidelberg, Germany

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM ( Dr Elias Mai - Heidelberg University, Heidelberg, Germany )

Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HER2 positive early BC

Dr Oleg Gluz - Evangeliches Krankenhaus Bethesda Klinik, Mönchengladbach, Germany

Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HER2 positive early BC ( Dr Oleg Gluz - Evangeliches Krankenhaus Bethesda Klinik, Mönchengladbach, Germany )

OncoAlert round up July 28th to August 3rd, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert round up July 28th to August 3rd, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

Precision oncology: Present and future in breast cancer

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

Precision oncology: Present and future in breast cancer ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

Imaging advances for breast surgery

Prof Mehra Golshan - Yale School of Medicine, New Haven, USA

Imaging advances for breast surgery ( Prof Mehra Golshan - Yale School of Medicine, New Haven, USA )

Personalised risk-stratified breast cancer screening for BRCA germline mutations and other genes

Prof Banu Arun - MD Anderson Cancer Center, Houston, USA

Personalised risk-stratified breast cancer screening for BRCA germline mutations and other genes ( Prof Banu Arun - MD Anderson Cancer Center, Houston, USA )

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy in locally advanced rectal cancer

Dr Thomas George - University of Florida Health Cancer Center, Gainesville, USA

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy in locally advanced rectal cancer ( Dr Thomas George - University of Florida Health Cancer Center, Gainesville, USA )

Breast-conserving therapy may be option for multiple breast lesions

Dr Judy Boughey - Mayo Clinic, Rochester, USA

Breast-conserving therapy may be option for multiple breast lesions ( Dr Judy Boughey - Mayo Clinic, Rochester, USA )

More from ecancer